Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2024 Earnings Call Transcript

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2024 Earnings Call Transcript November 7, 2024

Iovance Biotherapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27547, expectations were $-0.3.

Operator: Thank you for standing by. My name is Mandeep and I’ll be your operator today. I’d like to welcome everyone to the Iovance Third Quarter 2024 Financial Results Call. I would now like to turn the call over to Sara.

Sara Pellegrino: Thank you, operator. Good afternoon, and thank you...